Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

NCT00540345 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: pegylated interferon alpha 2a and plus ribavirin
DRUG: Pegylated interferon alfa-2a and ribavirin
DRUG: pegylated interferon alpha 2a and ribavirin
DRUG: pegylated interferon alpha 2a and ribavirin

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital